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Abstract 
Opioid Use Disorder (OUD) is defined as deviating from the physician’s prescription of a specific opioid. 
The OUD patients will require expensive inpatient treatment followed by a long-term outpatient treatment. 
We present a decision support system for opioid prescriptions, inpatient treatment (detoxification), and 
outpatient treatment by healthcare professionals. We analyzed the impact of inaccuracy in PDMP, decision 
scenarios, and effectiveness of decisions in outpatient scenarios on the opioid resource requirements. The 
proposed DSS will lead to better decision making using both the risk score and patient’s condition. 
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Introduction 
The use of prescription opioids has increased exponentially in the last decade.  Opioid Use Disorder (OUD) 
is defined as deviating from the physician’s prescription of a specific opioid (Finley et al. 2017; Sinha et al. 
2017). According to NIH, the total cost of opioid abuse in the US is approaching $100B per year with more 
than 2 million people misusing opioids (NIH 2019). OUD has become a major societal challenge for 
patients, family members, healthcare professionals, regulators, and society. The susceptibility to OUD is 
related to the type of opioid prescribed and medical condition (co-morbidities) of the patient including 
current and past conditions. This could lead to three different forms of OUD (mild, moderate, or severe) 
(APA 2013), all of which are considered and treated as chronic diseases. The OUD patients at any of the 
three levels, with or without overdose events, will require expensive inpatient treatment (Chintha et al. 
2018; Ivanov and Tacheva 2018) followed by a long-term outpatient treatment.  
In this paper, we focus on the factors behind the increased availability of prescriptions for opioids. Even 
with awareness, healthcare professionals underestimate the risks of opioid abuse (Brown et al. 2011). This 
along with the level of workload can result in prescription decisions that are sub-optimal. A Center for 
Disease Control study shows an urgent need for improved prescribing practices (CDC 2015). The study 
found that prescribing practices varied widely among states and a small minority of prescribers were 
responsible for most prescriptions. The findings provide extensive support for improving opioid prescribing 
practices (CDC 2015).  
Many healthcare professionals rely on individual state’s Prescription Drug Monitoring Program (PDMP), 
which are statewide databases containing prescriber and patient-level prescription data on select drugs of 
abuse. These databases are used by medical professionals or law enforcement officials to identify patients 
with prescription drug use patterns indicative of abuse or providers engaging in illegal activities (Reifler et 
al. 2012). There are numerous challenges with relying only on PDMPs alone. These include (a) lack of 
awareness related to detailed functionalities of PDMPs, (b) lack of interoperability among different states, 
(c) varying goals, objectives, and functionalities of different programs, (d) lack of effectiveness due to the 
reliance on intra-state prescriptions and not able to track all prescriptions and polypharmacy across states, 
and (e) not comprehensive and reliable enough to be the only source of information for decision making. 
The epidemic can be addressed by several different interventions such as monitoring (Varshney 2015). In 
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this paper, we focus on a proactive intervention, which involves providing comprehensive information 
related to potential misuse and abuse of medications to healthcare professionals. More specifically, we 
present a decision support system to improve decisions related to opioid prescriptions, inpatient treatment 
(detoxification), and outpatient treatment by healthcare professionals.  
The contributions of this paper are (a) literature review of how decision support for a prescription is studied 
in the literature, (b) decision support system (DSS) for opioid prescriptions by healthcare professionals, 
and (c) model and results to study the impact of interventions. In the next section, we present the literature 
review for decision support, followed by some results. Finally, the discussion and conclusion are presented. 
Literature Review 
We performed a comprehensive literature search on “Opioid AND Prescription AND (Intervention OR 
management OR decision)” in Web of Science, PubMed, MEDLINE, IEEE Xplore, ACM, and AIS e-library 
databases (Figure 1).  We identified a total of 127 articles. After removing 69 duplicate and/or redundant 
articles, 58 articles were assessed to explore the interventions by healthcare professionals for prescribing 
opioids. Further, 43 articles were not focusing on interventions for healthcare professionals. Finally, the 
remaining 15 articles were analyzed for decision making by the healthcare professionals for prescribing 
opioids. The classification of articles (Table 1) includes: therapeutic intervention (2 articles), educational 
intervention (2 articles), decision support system (4 articles), composite interventions (3 articles), and 
regulatory interventions (4 articles). These categories are not necessarily disjoint. For example, multiple 
strategies by healthcare professionals (HP) may be influenced by regulatory theme. Multiple strategies may 
also include DSS as one component. The education may involve learning of DSS components such as 
Prescription Drug Monitoring Programs (PDMPs). Regulatory intervention may also affect the design, 
implementation, and use of DSS such as PDMPs.  
 
 
Figure 1. Literature Review of Interventions for Opioid Prescription 
 
Type of Intervention Frequency in our Sample 
Therapeutic alliance (patient and HP/pharmacist)  2 
Educational intervention for HP 2 
DSS for HP 4 
Composite interventions by HP 3 
Regulatory 4 
Total = 5 types of interventions Total = 15 
Table 1. State and Federal Monitoring on ORR 
Identification Screening Eligibility Inclusion
Search terms “Opioid”
AND “Prescription”
AND (“Intervention OR
Management OR
Decision”) in the Title 
of the following sources:
Web of Science = 58
PubMed = 28
MEDLINE = 41
IEEE = 0
ACM = 0
AIS eLib = 0
Articles 
identified for 
screening = 127
Removed 
duplicate and 
redundant 
articles = 69
Articles assessed for 
eligibility (Criterion: 
Intervention for 
Healthcare 
Professionals) = 58
Excluded articles 
not focusing on 
Intervention for 
Healthcare 
Professionals = 43
Articles included 
in qualitative 
analysis = 15
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Decision Support System for Healthcare Professionals 
The decision support system for healthcare professionals will be based on the concept of integrating PDMP 
data with EHR data (Shen and Li 2019). In this paper, we propose to integrate the information from 
multiple sources (Kyung and Lim 2019; Nassel et al. 2018) including smart medication box, self-reporting, 
and monitoring into the DSS. This information along with the clinical knowledge support from other 
healthcare professionals will help in developing a more robust prescription system. In addition to monitor 
the past prescription patterns for the patient this will add the risk score calculation functionality for 
healthcare professionals based on the current symptoms, history of substance abuse, and other health 
comorbidities of the patients.  
Model and Results 
Using the proposed DSS in the previous section and the three states of prescription, inpatient treatment, 
and outpatient treatment we developed a Markov chain model (Sonnenberg and Beck 1993) of decision 
making as shown in Figure A1 of Appendix. The detailed model is shown in Appendix A1 (Equations A1-A3, 
B1-B4, C1-C2). This model helps the healthcare professionals to analyze the opioid resource requirements 
(ORR). Table 2 shows that the inaccuracy or increasing error in PDMP will lead to less accurate 
prescriptions resulting in higher opioid resource requirements. Table 3 shows the ORR for different 
scenarios. Scenario 1 considers only the risk score, the scenario considers only the current condition of the 
patient, and scenario 3 considers both risk score and current condition. As shown in Table 3 when both risk 
scores and current conditions of the patient are considered the ORR is comparatively low. Table 4 shows 
the effectiveness of the decision made by doctors in outpatient treatment. We can see that as the 
effectiveness of decision making in outpatient treatment increases the opioid resource requirement 
decreases leading to better decision making with minimal resources. 
 
Inaccuracy Modified (actual) 
Risk Score 
Prescription 
Probability 
PP PI  PO Opioid Resource 
Requirements (ORR) 
0.0 0.50 (0.50) .625 .243 .454 .303 0.678 
0.25 0.438 (0.50) .656 .234 .460 .306 0.683 
0.5 0.375 (0.50) .688 .225 .465 .310 0.688 
0.75 0.313 (0.50) .719 .218 .469 .312 0.690 
1 0.25 (0.50) .750 .211 .474 .315 0.695 
Table 2. Impact of State and Federal Monitoring on ORR 
 
Decision Scenario Risk Score Prescription 
Probability 
PP PI  PO Opioid Resource 
Requirements (ORR) 
 
Scenario 1 (100% 
Risk) 
0.0 1.0 1.0 0.0 0.0 0.3 
0.25 0.75 0.348 0.391 0.261 0.626 
0.5 0.5 0.286 0.429 0.286 0.658 
0.75 0.25 0.348 0.391 0.261 0.626 
1.0 0.0 1.0 0.0 0.0 0.3 
 
 
Scenario 2 (100% 
current condition) 
0.0 0.75 1.0 0.0 0.0 0.3 
0.25 0.75 0.348 0.391 0.261 0.626 
0.5 0.75 0.211 0.474 0.316 0.695 
0.75 0.75 0.151 0.509 0.340 0.724 
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1.0 0.75 0.118 0.529 0.353 0.741 
 
 
Scenario 3 (50% 
risk and 50% 
current condition) 
0.0 0.875 1.0 0.0 0.0 0.3 
0.25 0.75 0.348 0.391 0.261 0.626 
0.5 0.625 0.243 0.454 0.303 0.678 
0.75 0.5 0.211 0.474 0.316 0.695 
1.0 0.375 0.211 0.474 0.316 0.695 
Table 3. The Role of Prescription decisions on ORR 
 
Effectiveness of Decisions in Outpatient 
Treatment 
PP PI  PO Opioid Resource 
Requirements  (ORR) 
0.0 0.0 0.667 0.333 0.834 
0.25 0.127 0.556 0.317 0.753 
0.5 0.243 0.454 0.303 0.678 
0.75 0.348 0.362 0.290 0.611 
1 0.444 0.278 0.278 0.550 
Table 4. Impact of Decision Making in Outpatient Treatment on ORR 
Discussion and Work in Progress 
The proposed DSS for healthcare professionals can improve decision making for prescription opioids. We 
analyzed the impact of inaccuracy in PDMP, decision scenarios, and effectiveness of decision making in 
outpatient scenarios on the opioid resource requirements. We observed that ORR is decreasing with a 
decrease in error, balanced consideration of risk score and current condition, and an increase in the 
effectiveness of outpatient treatment. This leads to the conclusion that the proposed DSS for healthcare 
professionals will lead to better decision making for healthcare professionals.  
Currently, we are working on getting results for the inpatient treatment state. We are working towards 
designing and evaluating nationwide drug monitoring systems by integrating state PDMP systems. Also, we 
have started evaluating the significance of decision support for HP at all three different states of OUD 
(prescription, inpatient treatment, and outpatient treatment). The goal of this comparison is to identify at 
which state decision making will be most effective. We are exploring the IT-support for decision making by 
healthcare professionals including doctors and pharmacists. 
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Appendix: 
 
Figure A1. Markov Model for Decision Making 
 
Solving the above chain, we obtain the following sets of equations. The steady-state probability of being in 
Prescription state (PP) is given as      
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The steady-state probability of being in inpatient treatment state (PI) is given by    
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Probability of being in outpatient treatment state (PO) is given by     
𝑃𝑃𝑂𝑂 = 1
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For Prescription state, 𝑃𝑃𝑃𝑃𝑃𝑃 = 1 − 𝑃𝑃𝑃𝑃𝐼𝐼  and 𝑃𝑃𝑃𝑃𝐼𝐼 = RiskScorePPRESC     (B1) PPRESC.Scenario1 = 1 − RiskScore       (B2)  PPRESC.Scenario2 = CurrentCondition      (B3)  PPRESC.Scenario3 = Weight1  (1 − RiskScore) + Weight2  CurrentCondition    (B4) 
Prescription probability for polypharmacy is  𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 = � �𝑁𝑁𝑅𝑅� (𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑅𝑅 (1 −𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃)𝑁𝑁−𝑅𝑅 𝑁𝑁
𝑅𝑅=1
  (C1) 
The Opioid Resource Requirements (ORR) 𝑂𝑂𝑂𝑂𝑂𝑂 = ∑ PI𝑂𝑂𝐼𝐼𝑀𝑀𝐼𝐼=1      (C2)  
